Jane Street’s Meridian Bioscience Inc VIVO Stock Holding History

Jane Street’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-9,400	Closed	-$296K	–	10579
2022 Q3	$296K	Sell	9,400 -19,600	-68%	-$635K	﹤0.01%	7616
2022 Q2	$882K	Sell	29,000 -35,100	-55%	-$949K	﹤0.01%	5725
2022 Q1	$1.66M	Sell	64,100 -4,800	-7%	-$114K	﹤0.01%	5099
2021 Q4	$1.41M	Sell	68,900 -18,300	-21%	-$351K	﹤0.01%	5228
2021 Q3	$1.68M	Buy	87,200 +36,600	+72%	+$730K	﹤0.01%	4839
2021 Q2	$1.12M	Buy	50,600 +38,300	+311%	+$812K	﹤0.01%	5590
2021 Q1	$323K	Buy	12,300 +2,000	+19%	+$47.6K	﹤0.01%	7582
2020 Q4	$193K	Buy	+10,300	New	+$192K	﹤0.01%	6968
2020 Q3	–	Sell	-10,600	Closed	-$247K	–	8207
2020 Q2	$247K	Buy	+10,600	New	+$154K	﹤0.01%	6112

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Jane Street's VIVO Position: Q1 2023 in Review

Jane Street sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 37,031 shares — an estimated $1.23M sold.

Jane Street first reported a position in VIVO in Q2 2013 and held it in 11 quarters. The position peaked at $1.23M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Jane Street reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Jane Street sold 37,031 Meridian Bioscience Inc shares in Q1 2023, an estimated $1.23M.
Jane Street first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 11 quarters.
Jane Street's Meridian Bioscience Inc position peaked at $1.23M in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.